(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 18.49% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Astrana Health's revenue in 2025 is $2,034,540,000.On average, 5 Wall Street analysts forecast ASTH's revenue for 2025 to be $147,522,414,128, with the lowest ASTH revenue forecast at $145,885,241,280, and the highest ASTH revenue forecast at $150,739,832,289. On average, 4 Wall Street analysts forecast ASTH's revenue for 2026 to be $168,458,639,452, with the lowest ASTH revenue forecast at $161,692,194,623, and the highest ASTH revenue forecast at $171,187,617,130.
In 2027, ASTH is forecast to generate $191,202,257,697 in revenue, with the lowest revenue forecast at $191,202,257,697 and the highest revenue forecast at $191,202,257,697.